Company Technologies Markets Collaborations Investors Careers Contact Search ENGINEERING SOLUTIONS Forging a New Frontier in Cellular Therapeutics: Oral ActoBiotics™ Biopharmaceuticals Precise Gene Expression: Proprietary RheoSwitch® Technology Platform Engineering Microbes for Commercial Products: From Fuels and Chemicals to APIs IN THE NEWS Intrexon Establishes First Collaboration with Dedicated Fund 10/1/2015 5:00:00 AM Intrexon and ZIOPHARM to Develop Immunotherapies for Treatment of Graft-Versus-Host Disease 9/28/2015 1:00:00 PM Intrexon Strengthens Leadership Team 9/28/2015 5:00:00 AM Fibrocell and Intrexon Provide Regulatory Update for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) 9/25/2015 5:20:00 AM Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Technologies UltraVector® RheoSwitch® Cell Systems Informatics Protein Engineering AttSite® Recombinases LEAP® Antibody Discovery Neurospora & Agaricus Platforms Endometrial Regenerative Cells BeyondBio™ Scientific Literature Markets Health Food Energy Environment Consumer Collaborations Exclusive Channel Collaborations Joint Ventures Intrexon Institute for Biomolecular Research Partnering Opportunities Investors Press Releases Stock Information Corporate Governance SEC Filings Events/Conferences Investors Packet FAQ Information Request IRS Form 8937 Careers Contact Legal Notices © 2015 Intrexon

Company Technologies Markets Collaborations Investors Careers Contact Search Our Platform Intrexon's technology platform and Better DNA® approach presents a "one stop shop" for start-to-finish conceptualization, engineering, regulation, optimization and production of biologically-based solutions which possess many advantages over traditional processes. Our leading-edge toolkit can empower many cell platforms allowing for selection of the most effective host to create a desired product or solution for our partners. Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Technologies UltraVector® RheoSwitch® Cell Systems Informatics Protein Engineering AttSite® Recombinases LEAP® Antibody Discovery Neurospora & Agaricus Platforms Endometrial Regenerative Cells BeyondBio™ Scientific Literature Markets Health Food Energy Environment Consumer Collaborations Exclusive Channel Collaborations Joint Ventures Intrexon Institute for Biomolecular Research Partnering Opportunities Investors Press Releases Stock Information Corporate Governance SEC Filings Events/Conferences Investors Packet FAQ Information Request IRS Form 8937 Careers Contact Legal Notices © 2015 Intrexon